FDA Approved: DEXAMETHASONE INTENSOL — Supplemental Application (Hikma Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for DEXAMETHASONE INTENSOL from Hikma Pharmaceuticals USA, Inc., a dexamethasone product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenal Insufficiency
• Allergic Conditions
• Asthma
• Autoimmune Diseases
• Cerebral Edema
• Chemotherapy-induced Nausea and Vomiting
• Dermatitis
• Inflammation

Drugs mentioned

• DEXAMETHASONE INTENSOL (dexamethasone)

Snippet

SUPPL AP for DEXAMETHASONE INTENSOL (DEXAMETHASONE INTENSOL)